| scholarly article | Q13442814 |
| P50 | author | Kathryn Aston-Mourney | Q59601236 |
| P2093 | author name string | G Morahan | |
| S Andrikopoulos | |||
| J Proietto | |||
| P2860 | cites work | Pancreatic beta-cell failure and diabetes in mice with a deletion mutation of the endoplasmic reticulum molecular chaperone gene P58IPK | Q55847305 |
| Beta-cell dysfunction in nondiabetic HLA identical siblings of insulin-dependent diabetics | Q71470121 | ||
| Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats | Q72723734 | ||
| Association of a variant in exon 31 of the sulfonylurea receptor 1 (SUR1) gene with type 2 diabetes mellitus in French Caucasians | Q73074696 | ||
| K(ATP) channel openers protect rat islets against the toxic effect of streptozotocin | Q74052004 | ||
| Metabolic diapause in pancreatic beta-cells expressing a gain-of-function mutant of the forkhead protein Foxo1 | Q79362559 | ||
| Role of insulin resistance in predicting progression to type 1 diabetes | Q80400738 | ||
| Evidence for a role of superoxide generation in glucose-induced beta-cell dysfunction in vivo | Q80756060 | ||
| Free fatty acid-induced reduction in glucose-stimulated insulin secretion: evidence for a role of oxidative stress in vitro and in vivo | Q80838553 | ||
| EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome | Q28142981 | ||
| Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene | Q28469173 | ||
| Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival | Q28593963 | ||
| Hydroperoxide metabolism in mammalian organs | Q29614205 | ||
| Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy | Q29620534 | ||
| Insulin resistance and antidiabetic drugs | Q33760266 | ||
| Differential effect of inbred mouse strain (C57BL/6, DBA/2, 129T2) on insulin secretory function in response to a high fat diet | Q34458277 | ||
| Islet beta cell failure in type 2 diabetes | Q34698810 | ||
| Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells | Q34724292 | ||
| How mitochondrial damage affects cell function | Q34953719 | ||
| Endoplasmic reticulum stress and diabetes mellitus. | Q35065115 | ||
| A new pharmacology--drugging stressed folding pathways. | Q36187852 | ||
| Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities | Q36321572 | ||
| Endoplasmic reticulum stress signaling in disease | Q36610455 | ||
| Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). | Q37371843 | ||
| Transcriptional regulation of the endoplasmic reticulum stress gene chop in pancreatic insulin-producing cells | Q38303252 | ||
| Improvement in insulin secretion in diabetes after diazoxide | Q39368203 | ||
| High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes | Q40137823 | ||
| Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes | Q40176269 | ||
| Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress | Q40527936 | ||
| The endoplasmic reticulum stress response is stimulated through the continuous activation of transcription factors ATF6 and XBP1 in Ins2+/Akita pancreatic beta cells. | Q40581298 | ||
| A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. | Q40734688 | ||
| Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes. | Q41756772 | ||
| Glucose homeostasis in the nonobese diabetic mouse at the prediabetic stage | Q42451830 | ||
| High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction | Q42482387 | ||
| The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy | Q43935515 | ||
| Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure | Q44000598 | ||
| A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1. | Q44297979 | ||
| Coupling of beta-cell desensitization by hyperglycemia to excessive stimulation and circulating insulin in glucose-infused rats | Q44443777 | ||
| Insulin resistance is a risk factor for progression to type 1 diabetes | Q45103752 | ||
| Sulfonylurea induced beta-cell apoptosis in cultured human islets | Q45105959 | ||
| A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice | Q45281560 | ||
| Functional and molecular defects of pancreatic islets in human type 2 diabetes | Q45285356 | ||
| Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis | Q46744627 | ||
| Increased nicotinamide nucleotide transhydrogenase levels predispose to insulin hypersecretion in a mouse strain susceptible to diabetes. | Q46961703 | ||
| Variant in sulfonylurea receptor-1 gene is associated with high insulin concentrations in non-diabetic Mexican Americans: SUR-1 gene variant and hyperinsulinemia. | Q51567104 | ||
| Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity. | Q51595447 | ||
| Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. | Q53787751 | ||
| The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. III. Effect of H-2 haplotype and sex. | Q54527758 | ||
| The influence of genetic background on the induction of oxidative stress and impaired insulin secretion in mouse islets. | Q54611520 | ||
| Familial hyperinsulinism caused by an activating glucokinase mutation | Q55670538 | ||
| P433 | issue | 4 | |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | 540-545 | |
| P577 | publication date | 2008-02-02 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Too much of a good thing: why it is bad to stimulate the beta cell to secrete insulin | |
| P478 | volume | 51 |
| Q27310129 | A low-carbohydrate high-fat diet increases weight gain and does not improve glucose tolerance, insulin secretion or β-cell mass in NZO mice |
| Q47374720 | A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats |
| Q47096488 | Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance |
| Q34008552 | Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma |
| Q37668822 | Bisphenol A Is More Potent than Phthalate Metabolites in Reducing Pancreatic β-Cell Function |
| Q48146168 | Diabetes Mellitus and Risk of Hepatocellular Carcinoma. |
| Q42996831 | Do insulinotropic glucose-lowering drugs do more harm than good? The hypersecretion hypothesis revisited |
| Q36279518 | Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitro |
| Q37199572 | Effects of dietary fat subtypes on glucose homeostasis during pregnancy in rats |
| Q44186891 | Elevated levels of branched-chain amino acids have little effect on pancreatic islet cells, but L-arginine impairs function through activation of the endoplasmic reticulum stress response |
| Q38056123 | Endoplasmic reticulum stress in diabetes: New insights of clinical relevance |
| Q37163504 | GPR40: good cop, bad cop? |
| Q42459504 | Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia |
| Q38744831 | Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest? |
| Q81157739 | Insulin may have a role to play in protecting beta cells from deterioration in diabetes |
| Q33930824 | Lipid receptors and islet function: therapeutic implications? |
| Q77792823 | Maternal urinary phthalate metabolites in relation to gestational diabetes and glucose intolerance during pregnancy |
| Q24653018 | Molecular physiology of mammalian glucokinase |
| Q42177561 | Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27). |
| Q36867430 | Pioglitazone acutely reduces energy metabolism and insulin secretion in rats |
| Q24642826 | Pioglitazone acutely reduces insulin secretion and causes metabolic deceleration of the pancreatic beta-cell at submaximal glucose concentrations |
| Q24314902 | Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis |
| Q57496161 | Visualization of methylglyoxal in living cells and diabetic mice model with a 1,8-naphthalimide-based two-photon fluorescent probe |
Search more.